Internal Medicine, Endocrinology, Diabetes, & Metabolism · Evansville, IN
NPI
1467653402
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3801 Bellemeade Ave, Ste 110
Evansville, IN, 47714
Phone (812) 485-1400
Groups this clinician bills Medicare through
Medicare paid, 2024
$259K
3,763 services
Medicare patients, 2024
1,427
Average age 73
Drug cost, 2024
$6.9M
13,596 prescriptions
Company payments, 2025
$105
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vishal Bhatia was code 99214 (office e&m - established), 1,764 times for 1,102 patients. In total Vishal Bhatia billed 3,763 services in 14 codes, and Medicare paid $259K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,764 | 1,102 | $85.62 | $151K |
| 83036 Blood Count | Office | 479 | 379 | $9.26 | $4,435 |
| 99232 Hospital E&M - Subsequent | Facility | 440 | 102 | $57.95 | $25K |
| 76536 Ultrasound - Nonspecific | Office | 291 | 233 | $74.15 | $22K |
| 99213 Office E&M - Established | Office | 194 | 158 | $60.84 | $12K |
| 99204 Office E&M - New | Office | 193 | 193 | $113.52 | $22K |
| 99222 Hospital E&M - Initial | Facility | 147 | 145 | $96.74 | $14K |
| 10005 Other Organ Systems | Office | 63 | 63 | $95.48 | $6,015 |
| 99441 Telephone Services | Office | 12 | 11 | $28.91 | $347 |
By year: 2022 $236K for 3,751 services; 2023 $277K for 4,116 services; 2024 $259K for 3,763 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 479 | 379 | $9.26 | $4,435 |
Medicare prescription drug claims, 2024
In 2024, the drug Vishal Bhatia prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,183 prescriptions and refills. In total Vishal Bhatia wrote 13,596 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,183 | 5,981 | 645 | $20K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 983 | 2,512 | 364 | $212K |
| Metformin Hcl Generic | 676 | 1,839 | 210 | $8,651 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 669 | 1,742 | 298 | $111K |
| Glimepiride Generic | 521 | 1,442 | 166 | $2,389 |
| Jardiance Empagliflozin | 490 | 1,150 | 153 | $667K |
| Novolog Flexpen Insulin Aspart | 438 | 1,027 | 208 | $300K |
| Methimazole Generic | 417 | 1,132 | 139 | $3,233 |
| Ozempic Semaglutide | 417 | 801 | 118 | $767K |
| Atorvastatin Calcium Generic | 386 | 1,076 | 134 | $2,698 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 342 | 826 | 125 | $236K |
| Humalog Kwikpen U-100 Insulin Lispro | 340 | 808 | 169 | $268K |
| Trulicity Dulaglutide | 315 | 607 | 96 | $603K |
| Synthroid Levothyroxine Sodium | 299 | 786 | 80 | $27K |
| Rosuvastatin Calcium Generic | 254 | 692 | 80 | $2,425 |
Brand drugs: 6,441 claims; generic drugs: 5,722 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vishal Bhatia $105 ($105 in general payments such as food, travel and fees) from 2 companies. The largest payer was Stryker Corporation with $65.56.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.